Zotum 1500mg Injection contains Cefuroxime, a second-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, septicemia, bone and joint infections, and surgical prophylaxis. Cefuroxime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The 1500mg dosage form is intended for intravenous or intramuscular administration, ensuring rapid and effective systemic distribution. Dosage and duration of therapy should be guided by the severity of infection, patient condition, and susceptibility of the causative organism. Caution is advised in patients with a history of hypersensitivity to cephalosporins or penicillins due to potential cross-reactivity. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and local injection site reactions. Renal function should be monitored during prolonged therapy, and dose adjustment may be necessary in renal impairment. Zotum 1500mg Injection should be used under strict medical supervision, adhering to antimicrobial stewardship principles to minimize the development of resistance. It is contraindicated in patients with known allergy to cefuroxime or any component of the formulation.